Evaluation of IL-10 and IL-12 As Early Diagnostic Biomarkers in Type 2 Diabetes Mellitus
Maaen Journal for Medical Sciences · 05.03.2026 · 5 (1)
DOI: 10.55810/2789-9136.1092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maaen Journal for Medical Sciences, online erschienen am 05.03.2026. Verfasst von Mariam Sami Shail und 1 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is increasingly recognized as a complex metabolic disorder associated with immune dysregulation and chronic low-grade inflammation Objectives: This study aimed to quantify serum levels of (IL-10) and (IL-12) in patients with (T2DM) and to explore their potential role as early diagnostic biomarkers in comparison with healthy controls.
Methods
A case–control study be situated showed including 120 participants: 80 patients with T2DM and 40 healthy controls. Serum concentrations of IL-10 and IL-12 were quantified using ELISA. Hematological and biochemical parameters were assessed using standard automated methods. Statistical analyses included independent t-tests, correlation analysis, and receiver operating characteristic (ROC) curve analysis to evaluate diagnostic performance.
Results
Serum IL‑10 levels remained significantly lower in patients with T2DM related with controls (15.59 ± 5.79 vs. 20.53 ± 9.64 pg/mL, p = 0.01). Similarly, IL‑12 concentrations were significantly reduced in the patient group (15.31 ± 6.22 vs. 20.59 ± 8.43 pg/mL, p = 0.03). Patients also exhibited significantly higher HbA1c and WBC levels (p < 0.001). ROC analysis demonstrated that mutually IL‑10 and IL‑12 showed moderate diagnostic accuracy for distinguishing patients from controls.
Conclusion
Reduced serum levels of IL‑10 and IL‑12 reflect early immune dysregulation in T2DM and support their potential use as complementary diagnostic biomarkers alongside conventional metabolic indicators.
Zitieren
APA
Shail, M. S., & Hamzah, I. H. (2026). Evaluation of IL-10 and IL-12 As Early Diagnostic Biomarkers in Type 2 Diabetes Mellitus. Maaen Journal for Medical Sciences, 5(1). https://doi.org/10.55810/2789-9136.1092
Vancouver
Shail MS, Hamzah IH. Evaluation of IL-10 and IL-12 As Early Diagnostic Biomarkers in Type 2 Diabetes Mellitus. Maaen Journal for Medical Sciences. 2026;5(1). doi:10.55810/2789-9136.1092
BibTeX
@article{Shail2026,
author = {Shail, Mariam Sami and Hamzah, Israa Hussein},
title = {Evaluation of IL-10 and IL-12 As Early Diagnostic Biomarkers in Type 2 Diabetes Mellitus},
journal = {Maaen Journal for Medical Sciences},
year = {2026},
volume = {5},
number = {1},
doi = {10.55810/2789-9136.1092}
}
EUVIMED